No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs877282 |
chr10:771532-771533 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
disease
|
2 |
rs79108828 |
chr10:771534-771535 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs877281 |
chr10:771557-771558 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
4 |
rs34448709 |
chr10:771579-771580 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs554932983 |
chr10:771596-771597 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs575101635 |
chr10:771598-771599 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs877280 |
chr10:771599-771600 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
8 |
rs189274788 |
chr10:771600-771601 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs577410884 |
chr10:771628-771629 |
Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs116035267 |
chr10:771640-771641 |
Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs562977999 |
chr10:771646-771647 |
Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs147939717 |
chr10:771670-771671 |
Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs373387335 |
chr10:771675-771676 |
Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs561002780 |
chr10:771706-771707 |
Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs562008737 |
chr10:771714-771715 |
Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs530036493 |
chr10:771715-771716 |
Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs114949244 |
chr10:771717-771718 |
Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs114982977 |
chr10:771729-771730 |
Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs115759234 |
chr10:771743-771744 |
Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs114206089 |
chr10:771745-771746 |
Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs10904549 |
chr10:771769-771770 |
Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
22 |
rs115268875 |
chr10:771789-771790 |
Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs377277579 |
chr10:771837-771838 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs554580954 |
chr10:771838-771839 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs114277434 |
chr10:771842-771843 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs140718191 |
chr10:771843-771844 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs34338917 |
chr10:771850-771851 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs12782447 |
chr10:771870-771871 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
29 |
rs11253363 |
chr10:771891-771892 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
30 |
rs546433763 |
chr10:771916-771917 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs556665102 |
chr10:771938-771939 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs386739768 |
chr10:771939-771940 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs185235860 |
chr10:771940-771941 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs12763443 |
chr10:771941-771942 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
35 |
rs563653974 |
chr10:771948-771949 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs529949173 |
chr10:771988-771989 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs540565630 |
chr10:772027-772028 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs114008532 |
chr10:772061-772062 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs189718164 |
chr10:772072-772073 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs11253364 |
chr10:772083-772084 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs568630679 |
chr10:772084-772085 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs367708120 |
chr10:772089-772090 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs138449021 |
chr10:772105-772106 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs534753656 |
chr10:772127-772128 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs568096703 |
chr10:772128-772129 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs12779159 |
chr10:772143-772144 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
47 |
rs554542534 |
chr10:772170-772171 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs571139854 |
chr10:772200-772201 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs34652870 |
chr10:772218-772219 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
50 |
rs34912955 |
chr10:772222-772223 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|